|
시장보고서
상품코드
1386123
개용 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)Dog Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
Lucintel
개용 백신 동향과 예측
세계 개용 백신 시장은 2024년부터 2030년까지 5.7%의 CAGR로 2030년까지 약 46억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 반려견의 사육 수 증가, 반려견의 예방적 건강 관리에 대한 보호자의 인식 증가, 예방 접종에 대한 정부 규제 등입니다. 세계 개용 백신 시장의 미래는 동물병원 및 클리닉 시장과 반려동물 소유자 시장에서의 사업 기회로 인해 유망한 시장으로 평가됩니다.
개용 백신 시장 인사이트
Lucintel은 개 감염증이 증가하고 있고 다른 백신에 비해 더 편리하고 효과적인 백신이기 때문에 약독성 생백신이 가장 큰 부문이 될 것으로 예상하고 있습니다.
이 시장 중 동물병원 및 진료소는 예측 기간 동안 높은 성장세를 보일 것으로 예상됩니다.
북미 지역은 심각한 질병으로부터 개를 보호하는 동시에 개에게 물리지 않도록 인명을 보호하기 위해 백신 접종에 대한 엄격한 정부 규제가 있기 때문에 계속해서 가장 큰 지역이 될 것입니다.
시장 규모 및 추정치: 개용 백신 시장 규모를 금액(10억 달러)으로 추정.
동향 및 예측 분석: 다양한 부문 및 지역별 시장 동향(2018-2023년)과 예측(2024-2030년)을 분석합니다.
세분화 분석: 애견 백신 시장 규모를 유형별, 연령별, 최종 용도별, 지역별 금액(10억 달러)으로 분석.
지역별 분석: 북미, 유럽, 아시아태평양, 기타 지역의 개용 백신 시장 분석.
성장 기회: 애견 백신 종류, 연령, 최종 용도, 지역별 성장 기회 분석.
전략 분석: 개용 백신 시장 M&A, 신제품 개발, 경쟁 상황 등.
Porter's Five Forces 모델을 기반으로 한 산업 경쟁 강도 분석.
이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:
- Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
- Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
- Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
- Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
- Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
- Q.6. 이 시장의 새로운 트렌드와 그 이유는?
- Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
- Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
- Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
- Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
- Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?
목차
제1장 주요 요약
제2장 세계의 개용 백신 시장 : 시장 역학
- 서론, 배경, 분류
- 공급망
- 업계 성장 촉진요인과 과제
제3장 2018년부터 2030년까지 시장 동향과 예측 분석
- 거시경제 동향(2018-2023년)과 예측(2024-2030년)
- 세계의 개용 백신 시장 동향(2018-2023년)과 예측(2024-2030년)
- 유형별 세계 개용 백신 시장
- 약독화 생백신
- 결합 백신
- 불활화 백신
- 아단위 백신
- 톡소이드 백신
- DNA 백신
- 재조합 백신
- 연령별 세계 개용 백신 시장
- 6개월 미만
- 6개월 이상
- 최종 용도별 세계 개용 백신 시장
- 동물 병원과 클리닉
- 반려동물 주인
- 기타
제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석
- 지역별 세계의 개용 백신 시장
- 북미의 개용 백신 시장
- 유럽의 개용 백신 시장
- 아시아태평양의 개용 백신 시장
- 기타 지역의 개용 백신 시장
제5장 경쟁 분석
- 제품 포트폴리오 분석
- 운영상 통합
- Porter's Five Forces 분석
제6장 성장 기회와 전략적 분석
- 성장 기회 분석
- 종류별 세계 개용 백신 시장 성장 기회
- 연령별 세계 개용 백신 시장 성장 기회
- 최종 용도별 세계 개용 백신 시장 성장 기회
- 지역별 세계의 개용 백신 시장 성장 기회
- 세계의 개용 백신 시장의 새로운 동향
- 전략적 분석
- 신제품의 개발
- 세계의 개용 백신 시장 능력 확대
- 세계의 개용 백신 시장 합병, 인수, 합작투자
- 인증과 라이선싱
제7장 유력 기업의 기업 개요
- Bayer
- Vetquinol
- Boehringer Ingelhiem
- Ceva
- Eli Lilly
- Heska
- Merck
Dog Vaccine Trends and Forecast
The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.
A more than 150-page report is developed to help in your business decisions.
Dog Vaccine by Segment
The study includes a forecast for the global dog vaccine by type, age, end use, and region.
Dog Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccine
Dog Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:
- Below 6 Months
- Above 6 Months
Dog Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Veterinary Hospitals & Clinics
- Pet Owners
- Others
Dog Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Dog Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-
- Bayer
- Vetquinol
- Boehringer Ingelhiem
- Ceva
- Eli Lilly
- Heska
- Merck
Dog Vaccine Market Insights
Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.
Within this market, veterinary hospital & clinic is expected to witness higher growth over the forecast period.
North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.
Features of the Global Dog Vaccine Market
Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).
Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the dog vaccine market size?
Answer: The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030.
Q.2 What is the growth forecast for dog vaccine market?
Answer: The global dog vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the dog vaccine market?
Answer: The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.
Q4. What are the major segments for dog vaccine market?
Answer: The future of the dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets.
Q5. Who are the key dog vaccine market companies?
Answer: Some of the key dog vaccine companies are as follows:
- Bayer
- Vetquinol
- Boehringer Ingelhiem
- Ceva
- Eli Lilly
- Heska
- Merck
Q6. Which dog vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.
Q7. In dog vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, dna vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Dog Vaccine Market : Market Dynamics
- 2.1: Introduction, Background, and Classifications
- 2.2: Supply Chain
- 2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
- 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
- 3.2. Global Dog Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
- 3.3: Global Dog Vaccine Market by Type
- 3.3.1: Attenuated Live Vaccines
- 3.3.2: Conjugate Vaccines
- 3.3.3: Inactivated Vaccines
- 3.3.4: Subunit Vaccines
- 3.3.5: Toxoid Vaccines
- 3.3.6: DNA Vaccines
- 3.3.7: Recombinant Vaccine
- 3.4: Global Dog Vaccine Market by Age
- 3.4.1: Below 6 months
- 3.4.2: Above 6 months
- 3.5: Global Dog Vaccine Market by End Use
- 3.5.1: Veterinary Hospitals & Clinics
- 3.5.2: Pet Owners
- 3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
- 4.1: Global Dog Vaccine Market by Region
- 4.2: North American Dog Vaccine Market
- 4.2.2: North American Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
- 4.3: European Dog Vaccine Market
- 4.3.1: European Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
- 4.3.2: European Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
- 4.4: APAC Dog Vaccine Market
- 4.4.1: APAC Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
- 4.4.2: APAC Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
- 4.5: ROW Dog Vaccine Market
- 4.5.1: ROW Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
- 4.5.2: ROW Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
5. Competitor Analysis
- 5.1: Product Portfolio Analysis
- 5.2: Operational Integration
- 5.3: Porter's Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
- 6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
- 6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
- 6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use
- 6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region
- 6.2: Emerging Trends in the Global Dog Vaccine Market
- 6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Dog Vaccine Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
- 6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
- 7.1: Bayer
- 7.2: Vetquinol
- 7.3: Boehringer Ingelhiem
- 7.4: Ceva
- 7.5: Eli Lilly
- 7.6: Heska
- 7.7: Merck
